Cases
The list below contains only the cases for which the IJF is the Results Management Authority. For national cases please consult the relevant national anti-doping agencies.
| Name | Nationality | Antidoping Rules Violation | Prohibited substance or method | Consequence | Status |
|---|---|---|---|---|---|
| PENCUE, Nikol | COL | 2.1 Presence | S5. Diuretics and Masking Agents - furosemide | 3 years (13 May 2023 - 12 May 2026) | agreement |
| SAINI, Jasleen Singh | IND | 2.1 Presence | S1.1 Anabolic Androgenic Steroids - Methyltestosterone, S.1 Other Anabolic Agents - SARMS Ebonosarm (ostarine) | 3 years (27 July 2023 - 26 July 2026) | agreement |
| RODRIGUEZ, Elvismar | VEN | 2.4 Whereabouts | 20 months (3 December 2024 - 2 August 2026) | CAS ADD decision | |
| YSTYBAI, Aibolat | KAZ | 2.1 Presence | S1.1 Anabolic Androgenic Steroids - Drostanolone | 3 years (5 September 2023 - 4 September 2026) | agreement |
| KEVLISHVILI, Davit | ESP | 2.1 Presence | S5. Diuretics and Masking Agents - Hydrochlorothiazide | 2 years (30 September 2024 - 29 September 2026) | agreement |
| CHILARD, Nicolas | FRA | 2.1 Presence | S1.2 Other Anabolic Agents - SARMS Ebonosarm (ostarine) | 4 years (7 December 2022 - 6 December 2026) | CAS Decision |
| CHANG, Ching-Ying | TPE | 2.1 Presence | S5. Diuretics and Masking Agents - furosemide | 2 years (19 March 2025 - 18 March 2027) | agreement |
| NIANGI, Maria | ANG | 2.1 Presence | S5. Diuretics and Masking Agents - furosemide | 4 years (17 May 2024 - 16 May 2028) | agreement |
| GABRIEL, Vania | ANG | 2.1 Presence | S5. Diuretics and Masking Agents - Hydrochlorothiazide | 4 years (24 May 2024 - 23 May 2028) | agreement |
| SEHEN, Sajjad | IRQ | 2.1 Presence | S1.1 Anabolic Androgenic Steroids - Metandienone metabolites, Boldenone metabolites | 4 years (26 July 2024 - 25 July 2028) | final decision |
| FAIZADA, Mohammad Samim | AFG | 2.1 Presence | S1.1 Anabolic Androgenic Steroids - Stanozolol metabolites | 4 years (2 August 2024 - 1 August 2028) | final decision |
| GVINIASHVILI, Beka | GEO | 2.1 Presence | S1.2 Other anabolic agents - SARMS enobosarm (ostarine) | 4 years (22 May 2025 - 21 May 2029) | CAS decision |